Avisa Diagnostics Inc FOGCF

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates via its own delivery systems. Its ABT portfolio includes Post-Covid-19 Bronchiectasis, Develo, Ventilator-Associated Pneumonia (VAP), Chronic Obstructive Pulmonary Disease (COPD), Community-Acquired, Pneumonia (CAP), Cystic Fibrosis, Tuberculosis, Aspergillus Fungus and Clostridium Difficile (C. diff).

GREY:FOGCF - Post by User

Avisa Diagnostics Inc > .015 on the bid...

<< Previous

Bullboard Posts

Next >>

Comment by sawrieon Feb 04, 2021 4:13pm

114 Views

Post# 32475273

RE:.015 on the bid...

I placed an order for 150k shares at 2 and 130k shares has a market order in which is ahead of mine, so the 1.5 was put there to try and scare out shares: they don't really want to lose them.

<< Previous

Bullboard Posts

Next >>

TELUS adds 347K customers in Q3